Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jane LeBlanc"'
Autor:
Sarfraz Ahmad, Robert W. Holloway, Madhavi Manyam, Amanda J. Stephens, Jessica A. Kennard, James E. Kendrick, Jane LeBlanc
Publikováno v:
Gynecologic Oncology. 163:481-489
Objective Our objective was to assess safety and adverse events associated with intraperitoneal Olvi-Vec virotherapy in patients with platinum-resistant or refractory ovarian cancer (PRROC). Secondary objectives included objective response rate (ORR)
Autor:
Madhavi Manyam, Amanda J. Stephens, Jessica A. Kennard, Jane LeBlanc, Sarfraz Ahmad, James E. Kendrick, Robert W. Holloway
Publikováno v:
Gynecologic Oncology. 165:401
Autor:
Madhavi Manyam, Jessica A. Kennard, Sarfraz Ahmad, Amanda J. Stephens, Nathalie D. McKenzie, James E. Kendrick, Jamie L. Smith, Christine K. Fitzsimmons, Jane LeBlanc, Robert W. Holloway
Publikováno v:
Journal of Clinical Oncology. 37:e17070-e17070
e17070 Background: VIRO-15 phase IB trial included 11 patients (pts) with platinum-resistant ovarian cancer (PROC), extensive tumor burden and a median of 5 prior lines of therapy who were given intra-peritoneal Olvi-Vec (GL-ONC1), a modified vaccini
Autor:
Jane LeBlanc, Jeremy R. Burt, James E. Kendrick, Susan Coakley, Jamie L. Smith, Robert W. Holloway, Karen Sellers, Amanda J. Stephens, Jessica A. Kennard
Publikováno v:
Journal of Clinical Oncology. 36:5577-5577
5577Background: Immunotherapy can trigger immune activation including tumor-infiltrating CD8+ T cells, leading to antitumor response and survival benefits. Immunotherapeutic GL-ONC1 (modified vacci...